Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2025-12-24 @ 11:39 PM
NCT ID: NCT04916951
Eligibility Criteria: Inclusion Criteria: * Patients admitted to Children's Hospital Colorado derived from two groups: * Group 1-patients specifically receiving enteral amoxicillin (with or without clavulanate) or cephalexin for any clinical indication; * Group 2-patients receiving any IV antibiotic who are tolerating full enteral feeds and/or enteral medications. Exclusion Criteria: * Across both groups, exclusion criteria are: (1) weight \<2kg, (2) renal dysfunction, including the use of any renal replacement therapy, (3) significant β-lactam allergy, (4) GI disorders significantly impairing drug absorption, (5) use of external circuits that would affect the study drug's volume of distribution (e.g. ECMO), and (6) clinically significant anemia precluding study-related blood draws.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 1 Day
Maximum Age: 60 Days
Study: NCT04916951
Study Brief:
Protocol Section: NCT04916951